サマリー

経口固形剤（OSD）受託製造の世界市場 2023-2027
経口固形剤（OSD）の受託製造市場は、2022年から2027年にかけて115億7000万米ドルの成長が予測され、予測期間中のCAGRは6%で加速すると予測されています。当レポートでは、経口固形剤（OSD）の受託製造市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、特許切れとジェネリック医薬品需要の増加、コアコンピタンスへの注力ニーズの高まり、新興市場におけるコスト効率の高いリソースの利用可能性などが牽引しています。
Technavioの経口固形剤（OSD）受託製造市場は以下のように区分されます：
エンドユーザー別
- 大企業
- 中小企業
- 新興企業およびジェネリック医薬品企業
製品別
- 錠剤
- カプセル
- 粉末
- 顆粒その他
地域別
- アジア
- 北米
- ヨーロッパ
- その他の地域（ROW）
本調査では、今後数年間の経口固形剤（OSD）受託製造市場の成長を促進する主な理由の一つとして、米国FDA承認製造施設の増加を挙げている。また、OSDを製造するCMOによるアナリティクスの利用の増加や市場統合の増加は、市場の大きな需要につながる。
この調査レポートは、経口固形製剤（OSD）受託製造市場を調査・分析し、以下の調査分野をカバーしています：
- 経口固形剤（OSD）受託製造市場のサイジング
- 経口固形剤（OSD）の受託製造市場予測
- 経口固形剤（OSD）受託製造市場の産業分析
堅牢なベンダー分析は、顧客が市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Acino International AG、Aenova Holding GmbH、Beximco Pharmaceuticals Ltd.、Boehringer Ingelhey Ltd.などの経口固形剤（OSD）受託製造市場の主要ベンダー数社に関する詳細な分析を提供しています、Boehringer Ingelheim International GmbH、Catalent Inc.、Corden Pharma International GmbH、Inglasia Pharma Solutions、Jubilant Pharmova Ltd.、Koninklijke DSM NV、Lonza Group Ltd.、Merck KGaA、NextPharma GmbH、PerkinElmer Inc.、Piramal Enterprises Ltd.、Pyramid Laboratories Inc.、Recipharm AB、Siegfried Holding AG、Thermo Fisher Scientific Inc.、Viatris Inc.などです。また、経口固形剤（OSD）受託製造市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/oral-solid-dosage-osd-contract-manufacturing-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global oral solid dosage (OSD) contract manufacturing market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global oral solid dosage (osd) contract manufacturing market 2017 - 2021 ($ billion)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Large-size companies - Market size and forecast 2022-2027
o Exhibit 34: Chart on Large-size companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Large-size companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Large-size companies - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Large-size companies - Year-over-year growth 2022-2027 (%)
o 6.4 Small and medium size companies - Market size and forecast 2022-2027
o Exhibit 38: Chart on Small and medium size companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Small and medium size companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Small and medium size companies - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Small and medium size companies - Year-over-year growth 2022-2027 (%)
o 6.5 Startups and generic pharmaceutical companies - Market size and forecast 2022-2027
o Exhibit 42: Chart on Startups and generic pharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Startups and generic pharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Startups and generic pharmaceutical companies - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Startups and generic pharmaceutical companies - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ billion)
o Exhibit 47: Data Table on Market opportunity by End-user ($ billion)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Tablets - Market size and forecast 2022-2027
o Exhibit 52: Chart on Tablets - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Tablets - Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Tablets - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Tablets - Year-over-year growth 2022-2027 (%)
o 7.4 Capsules - Market size and forecast 2022-2027
o Exhibit 56: Chart on Capsules - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Capsules - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Capsules - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Capsules - Year-over-year growth 2022-2027 (%)
o 7.5 Powders - Market size and forecast 2022-2027
o Exhibit 60: Chart on Powders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Powders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Powders - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Powders - Year-over-year growth 2022-2027 (%)
o 7.6 Granules and others - Market size and forecast 2022-2027
o Exhibit 64: Chart on Granules and others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Granules and others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Granules and others - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Granules and others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Product
o Exhibit 68: Market opportunity by Product ($ billion)
o Exhibit 69: Data Table on Market opportunity by Product ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.4 North America - Market size and forecast 2022-2027
o Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.8 US - Market size and forecast 2022-2027
o Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.9 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 Germany - Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. - Overview
o Exhibit 120: AbbVie Inc. - Product / Service
o Exhibit 121: AbbVie Inc. - Key news
o Exhibit 122: AbbVie Inc. - Key offerings
o 12.4 Aenova Holding GmbH
o Exhibit 123: Aenova Holding GmbH - Overview
o Exhibit 124: Aenova Holding GmbH - Product / Service
o Exhibit 125: Aenova Holding GmbH - Key offerings
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 126: Boehringer Ingelheim International GmbH - Overview
o Exhibit 127: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 128: Boehringer Ingelheim International GmbH - Key news
o Exhibit 129: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 130: Boehringer Ingelheim International GmbH - Segment focus
o 12.6 Catalent Inc.
o Exhibit 131: Catalent Inc. - Overview
o Exhibit 132: Catalent Inc. - Business segments
o Exhibit 133: Catalent Inc. - Key news
o Exhibit 134: Catalent Inc. - Key offerings
o Exhibit 135: Catalent Inc. - Segment focus
o 12.7 Corden Pharma International GmbH
o Exhibit 136: Corden Pharma International GmbH - Overview
o Exhibit 137: Corden Pharma International GmbH - Product / Service
o Exhibit 138: Corden Pharma International GmbH - Key offerings
o 12.8 Jubilant Pharmova Ltd.
o Exhibit 139: Jubilant Pharmova Ltd. - Overview
o Exhibit 140: Jubilant Pharmova Ltd. - Business segments
o Exhibit 141: Jubilant Pharmova Ltd. - Key news
o Exhibit 142: Jubilant Pharmova Ltd. - Key offerings
o Exhibit 143: Jubilant Pharmova Ltd. - Segment focus
o 12.9 Lonza Group Ltd.
o Exhibit 144: Lonza Group Ltd. - Overview
o Exhibit 145: Lonza Group Ltd. - Business segments
o Exhibit 146: Lonza Group Ltd. - Key news
o Exhibit 147: Lonza Group Ltd. - Key offerings
o Exhibit 148: Lonza Group Ltd. - Segment focus
o 12.10 Merck KGaA
o Exhibit 149: Merck KGaA - Overview
o Exhibit 150: Merck KGaA - Business segments
o Exhibit 151: Merck KGaA - Key news
o Exhibit 152: Merck KGaA - Key offerings
o Exhibit 153: Merck KGaA - Segment focus
o 12.11 NextPharma GmbH
o Exhibit 154: NextPharma GmbH - Overview
o Exhibit 155: NextPharma GmbH - Product / Service
o Exhibit 156: NextPharma GmbH - Key offerings
o 12.12 PerkinElmer Inc.
o Exhibit 157: PerkinElmer Inc. - Overview
o Exhibit 158: PerkinElmer Inc. - Business segments
o Exhibit 159: PerkinElmer Inc. - Key news
o Exhibit 160: PerkinElmer Inc. - Key offerings
o Exhibit 161: PerkinElmer Inc. - Segment focus
o 12.13 Piramal Enterprises Ltd.
o Exhibit 162: Piramal Enterprises Ltd. - Overview
o Exhibit 163: Piramal Enterprises Ltd. - Business segments
o Exhibit 164: Piramal Enterprises Ltd. - Key offerings
o Exhibit 165: Piramal Enterprises Ltd. - Segment focus
o 12.14 Pyramid Laboratories Inc.
o Exhibit 166: Pyramid Laboratories Inc. - Overview
o Exhibit 167: Pyramid Laboratories Inc. - Product / Service
o Exhibit 168: Pyramid Laboratories Inc. - Key offerings
o 12.15 Recipharm AB
o Exhibit 169: Recipharm AB - Overview
o Exhibit 170: Recipharm AB - Business segments
o Exhibit 171: Recipharm AB - Key offerings
o Exhibit 172: Recipharm AB - Segment focus
o 12.16 Siegfried Holding AG
o Exhibit 173: Siegfried Holding AG - Overview
o Exhibit 174: Siegfried Holding AG - Business segments
o Exhibit 175: Siegfried Holding AG - Key offerings
o Exhibit 176: Siegfried Holding AG - Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 177: Thermo Fisher Scientific Inc. - Overview
o Exhibit 178: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 179: Thermo Fisher Scientific Inc. - Key news
o Exhibit 180: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 181: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global oral solid dosage (osd) contract manufacturing market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Large-size companies - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Large-size companies - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Large-size companies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Large-size companies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Small and medium size companies - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Small and medium size companies - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Small and medium size companies - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Small and medium size companies - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Startups and generic pharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Startups and generic pharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Startups and generic pharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Startups and generic pharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Product - Market share 2022-2027 (%)
Exhibits49: Data Table on Product - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Tablets - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Tablets - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Tablets - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Tablets - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Capsules - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Capsules - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Capsules - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Capsules - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Powders - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Powders - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Powders - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Powders - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Granules and others - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Granules and others - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Granules and others - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Granules and others - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Product ($ billion)
Exhibits69: Data Table on Market opportunity by Product ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. - Overview
Exhibits120: AbbVie Inc. - Product / Service
Exhibits121: AbbVie Inc. - Key news
Exhibits122: AbbVie Inc. - Key offerings
Exhibits123: Aenova Holding GmbH - Overview
Exhibits124: Aenova Holding GmbH - Product / Service
Exhibits125: Aenova Holding GmbH - Key offerings
Exhibits126: Boehringer Ingelheim International GmbH - Overview
Exhibits127: Boehringer Ingelheim International GmbH - Business segments
Exhibits128: Boehringer Ingelheim International GmbH - Key news
Exhibits129: Boehringer Ingelheim International GmbH - Key offerings
Exhibits130: Boehringer Ingelheim International GmbH - Segment focus
Exhibits131: Catalent Inc. - Overview
Exhibits132: Catalent Inc. - Business segments
Exhibits133: Catalent Inc. - Key news
Exhibits134: Catalent Inc. - Key offerings
Exhibits135: Catalent Inc. - Segment focus
Exhibits136: Corden Pharma International GmbH - Overview
Exhibits137: Corden Pharma International GmbH - Product / Service
Exhibits138: Corden Pharma International GmbH - Key offerings
Exhibits139: Jubilant Pharmova Ltd. - Overview
Exhibits140: Jubilant Pharmova Ltd. - Business segments
Exhibits141: Jubilant Pharmova Ltd. - Key news
Exhibits142: Jubilant Pharmova Ltd. - Key offerings
Exhibits143: Jubilant Pharmova Ltd. - Segment focus
Exhibits144: Lonza Group Ltd. - Overview
Exhibits145: Lonza Group Ltd. - Business segments
Exhibits146: Lonza Group Ltd. - Key news
Exhibits147: Lonza Group Ltd. - Key offerings
Exhibits148: Lonza Group Ltd. - Segment focus
Exhibits149: Merck KGaA - Overview
Exhibits150: Merck KGaA - Business segments
Exhibits151: Merck KGaA - Key news
Exhibits152: Merck KGaA - Key offerings
Exhibits153: Merck KGaA - Segment focus
Exhibits154: NextPharma GmbH - Overview
Exhibits155: NextPharma GmbH - Product / Service
Exhibits156: NextPharma GmbH - Key offerings
Exhibits157: PerkinElmer Inc. - Overview
Exhibits158: PerkinElmer Inc. - Business segments
Exhibits159: PerkinElmer Inc. - Key news
Exhibits160: PerkinElmer Inc. - Key offerings
Exhibits161: PerkinElmer Inc. - Segment focus
Exhibits162: Piramal Enterprises Ltd. - Overview
Exhibits163: Piramal Enterprises Ltd. - Business segments
Exhibits164: Piramal Enterprises Ltd. - Key offerings
Exhibits165: Piramal Enterprises Ltd. - Segment focus
Exhibits166: Pyramid Laboratories Inc. - Overview
Exhibits167: Pyramid Laboratories Inc. - Product / Service
Exhibits168: Pyramid Laboratories Inc. - Key offerings
Exhibits169: Recipharm AB - Overview
Exhibits170: Recipharm AB - Business segments
Exhibits171: Recipharm AB - Key offerings
Exhibits172: Recipharm AB - Segment focus
Exhibits173: Siegfried Holding AG - Overview
Exhibits174: Siegfried Holding AG - Business segments
Exhibits175: Siegfried Holding AG - Key offerings
Exhibits176: Siegfried Holding AG - Segment focus
Exhibits177: Thermo Fisher Scientific Inc. - Overview
Exhibits178: Thermo Fisher Scientific Inc. - Business segments
Exhibits179: Thermo Fisher Scientific Inc. - Key news
Exhibits180: Thermo Fisher Scientific Inc. - Key offerings
Exhibits181: Thermo Fisher Scientific Inc. - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations